These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3928091)

  • 1. Behavioural effects in the rat after acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sirinathsinghji DJ
    Brain Res; 1985 Jul; 339(2):366-70. PubMed ID: 3928091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat.
    Kelly E; Jenner P; Marsden CD
    Exp Brain Res; 1984; 55(2):243-52. PubMed ID: 6611272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal ganglia outflow pathways and circling behaviour in the rat.
    Leigh PN; Reavill C; Jenner P; Marsden CD
    J Neural Transm; 1983; 58(1-2):1-41. PubMed ID: 6418859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
    Bradbury AJ; Costall B; Domeney AM; Jenner PJ; Marsden CD; Naylor RJ
    Neurosci Lett; 1986 Jun; 67(2):208-12. PubMed ID: 2425303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
    Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates.
    Morelli M; Di Chiara G
    Brain Res; 1985 Aug; 341(2):350-9. PubMed ID: 2864100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotation induced by intranigral injections of GABA agonists and antagonists: zone-specific effects.
    Kozlowski MR; Marshall JF
    Pharmacol Biochem Behav; 1980 Oct; 13(4):561-7. PubMed ID: 7192000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned rotational behavior in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra.
    Carey RJ
    Brain Res; 1986 Feb; 365(2):379-82. PubMed ID: 3081236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat.
    Sahgal A; Andrews JS; Biggins JA; Candy JM; Edwardson JA; Keith AB; Turner JD; Wright C
    Neurosci Lett; 1984 Jul; 48(2):179-84. PubMed ID: 6333003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranigral methionine sulfoximine induces turning behaviour in the rat.
    Leon-Henri B; Gayet J
    Brain Res; 1984 Jan; 291(1):197-9. PubMed ID: 6320954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nigral dopaminergic mechanisms in drug-induced circling.
    Jackson EA; Kelly PH
    Brain Res Bull; 1983 Nov; 11(5):605-11. PubMed ID: 6607768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Cohen G; Mytilineou C
    Life Sci; 1985 Jan; 36(3):237-42. PubMed ID: 3917526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circling behavior in old rats after unilateral intranigral injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lange KW
    Life Sci; 1989; 45(18):1709-14. PubMed ID: 2531261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and biochemical assessment of time-related changes in globus pallidus and striatal dopamine induced by intranigrally administered neurotensin.
    Napier TC; Gay DA; Hulebak KL; Breese GR
    Peptides; 1985; 6(6):1057-68. PubMed ID: 3938838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.
    Hudson JL; van Horne CG; Strömberg I; Brock S; Clayton J; Masserano J; Hoffer BJ; Gerhardt GA
    Brain Res; 1993 Oct; 626(1-2):167-74. PubMed ID: 8281427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.